Trials / Conditions / ALI
ALI
4 registered clinical trials studyying ALI.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 NCT05137795 | APR Applied Pharma Research s.a. | Phase 3 |
| Terminated | Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 NCT04360096 | APR Applied Pharma Research s.a. | Phase 2 / Phase 3 |
| Withdrawn | A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure NCT04574869 | ReAlta Life Sciences, Inc. | Phase 1 |
| Unknown | Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS NCT04503057 | Lund University Hospital | — |